-
-
Call more information
660-596-2224 -
Repeated subcutaneous injections of botulinum toxin A (Botox, Allergan) provides analgesic relief to patients with neuropathic pain, a new randomized controlled trial has shown. The study showed that two series of injections were safe and effective for treating peripheral neuropathic pain, especially in a subgroup of patients with allodynia. This research is important because neuropathic […]
Read MoreFor patients undergoing genioplasty, the use of ultrasonic piezosurgery equipment reduces trauma, pain, and swelling, compared with traditional surgical drills, according to a study published in the Journal of Craniofacial Surgery. “Piezosurgery may be a viable alternative to traditional osteotomy technique, as it reduces the degree of inflammation, pain, swelling, and morbidity, improving satisfaction and […]
Read MorePipemidic acid, phenazopyridine HCl, and sodium diclofenac are effective for pain relief following endoscopic urology surgery without side effects, and it is safe when used in combination with antibiotics and anticoagulants, according to a study presented here at the 31st Annual European Association of Urology (EAU) Congress. However, pipemidic acid showed a superior analgesic effect […]
Read MoreResearchers have shown that patients who have chronic pain can reduce their emotional response to the pain through spinal cord stimulation. The study results are published in the latest issue of the journal Neuromodulation: Technology at the Neural Interface. “Our initial study provides insights into the role of the brain’s emotional networks in relieving chronic […]
Read MoreIn a large-scale analysis of pain-relief medication for osteoarthritis, researchers found that paracetamol does not meet the minimum standard of clinical effectiveness in reducing pain or improving physical function in patients with knee and hip osteoarthritis. Although paracetamol was slightly better than placebo, researchers concluded that, taken on its own, paracetamol has no role in […]
Read More